HomeCompareMEDRX vs DIVO

MEDRX vs DIVO: Dividend Comparison 2026

MEDRX yields 6.41% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIVO wins by $181.00 in total portfolio value
10 years
MEDRX
MEDRX
● Live price
6.41%
Share price
$31.22
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$963.09
Full MEDRX calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — MEDRX vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMEDRXDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MEDRX + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MEDRX pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MEDRX
Annual income on $10K today (after 15% tax)
$544.52/yr
After 10yr DRIP, annual income (after tax)
$818.63/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, DIVO beats the other by $15.80/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MEDRX + DIVO for your $10,000?

MEDRX: 50%DIVO: 50%
100% DIVO50/50100% MEDRX
Portfolio after 10yr
$30.6K
Annual income
$972.39/yr
Blended yield
3.17%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MEDRX buys
0
DIVO buys
0
No recent congressional trades found for MEDRX or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMEDRXDIVO
Forward yield6.41%6.49%
Annual dividend / share$2.00$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$30.5K$30.7K
Annual income after 10y$963.09$981.68
Total dividends collected$8.1K$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: MEDRX vs DIVO ($10,000, DRIP)

YearMEDRX PortfolioMEDRX Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$11,341$640.61$11,349$649.42$8.00DIVO
2$12,813$678.97$12,833$688.83$20.00DIVO
3$14,427$716.96$14,459$727.90$32.00DIVO
4$16,192$754.45$16,238$766.49$46.00DIVO
5$18,116$791.32$18,179$804.47$63.00DIVO
6$20,212$827.47$20,293$841.71$81.00DIVO
7$22,490$862.79$22,591$878.14$101.00DIVO
8$24,961$897.21$25,087$913.65$126.00DIVO
9$27,639$930.66$27,791$948.18$152.00DIVO
10$30,537$963.09$30,718$981.68$181.00DIVO

MEDRX vs DIVO: Complete Analysis 2026

MEDRXStock

The fund is a non-diversified fund that invests all of its investable assets in the Medical Portfolio, a series of Kinetics Portfolios Trust. The Portfolio invests at least 80% of its net assets plus any borrowings for investment purposes in common stocks, convertible securities, warrants, and other equity securities having the characteristics of common stocks of U.S. and foreign companies engaged in medical research, pharmaceutical and medical technology industries and related technology industries, with an emphasis toward companies engaged in cancer research and drug development. It is non-diversified.

Full MEDRX Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this MEDRX vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MEDRX vs SCHDMEDRX vs JEPIMEDRX vs OMEDRX vs KOMEDRX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.